Lv4
760 积分 2025-10-16 加入
Natural Killer and CAR-NK immunotherapy in breast cancer: bridging promise and the solid-tumor barrier
1个月前
已完结
Engineering and targeting potential of CAR NK cells in colorectal cancer
1个月前
已完结
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma
1个月前
已完结
PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma
1个月前
已完结
53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer
1个月前
已完结
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
1个月前
已完结
Epithelial ovarian cancer
3个月前
已完结
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
3个月前
已完结
Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer
4个月前
已完结
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
4个月前
已完结
皖公网安备34019202002308
